Scientists at Dana-Farber Cancer Institute and the Centers for Disease Control and Prevention have uncovered new evidence of the potential health risks of chemicals in tobacco and marijuana smoke.
The Icahn School of Medicine at Mount Sinai has launched a new center for psychedelics research. The Center for Psychedelic Psychotherapy and Trauma Research pursues a multipronged clinical and research approach to discovering novel and more efficacious therapies for post-traumatic stress disorder (PTSD), depression, anxiety, and other stress-related conditions in the veteran and civilian population.
Today, Wolters Kluwer, Health announced the publication of Cannabis: A Handbook for Nurses, the first medical cannabis book written specifically for nurses. The book addresses nursing skills and responsibilities in cannabis care, including the physiology of the human endocannabinoid system, cannabis care as it relates to specific disease processes, the history of cannabis, advocacy and ethics, and the ins and outs of cannabis dosing, delivery methods, side effects, and more.
Female rats that inhaled vaporized cannabis daily for a month developed a blunted physiological response to stress, according to a new study by Washington State University researchers.
New research suggests that cannabis use by people in care for opioid addiction might improve their treatment outcomes and reduce their risk of being exposed to fentanyl in the contaminated unregulated drug supply.
Camille Stewart's article about medical cannabis explains issues around the drug’s legality, makes recommendations for its use before and after surgery and pushes for research on its effects on postoperative patients.
A landmark study on how cannabis affects driving ability has shown that cannabidiol (CBD), a cannabis component now widely used for medical purposes, does not impair driving, while moderate amounts of the main intoxicating component tetrahydrocannabinol (THC) produce mild driving impairment lasting up to four hours.
Young adults who combine alcohol and cannabis use experience fewer negative consequences when they stick with a single type of drink versus consuming multiple types of alcohol, according to a new study. In addition, by avoiding cannabis concentrate they may steady or lower their overall consumption. The findings suggest that for those who choose to sustain their levels of alcohol and cannabis use, judicious choice of products may reduce the risks.
UCLA has received seven grants totaling $6.4 million from the California Bureau of Cannabis Control. The awards will fund studies on topics ranging from the toxicity of inhaled and second-hand cannabis smoke to employment conditions in California’s cannabis industry.
Before the COVID-19 pandemic, information about the dangers of vaping was emerging. To investigate the potentially serious health and respiratory implications of vaping, Mayo Clinic researchers wanted to better understand the factors influencing vaping in the community.
Cannabidiol (CBD) oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, according to Penn State College of Medicine researchers.
UC San Diego School of Medicine researchers report that older adults are increasingly using cannabis to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.
DALLAS – Oct. 7, 2020 – Endocannabinoids, signaling molecules produced in the body that share features with chemicals found in marijuana, can shut down genes needed for some pathogenic intestinal bacteria to colonize, multiply, and cause disease, new research led by UT Southwestern scientists shows.
At panel discussions during the virtual ACS Clinical Congress 2020, experts underscored the importance of helping patients stop tobacco, vaping and marijuana use before having an operation.
Not only might cannabis users require more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while in the hospital, suggests first-of-its kind research being presented at the ANESTHESIOLOGY® 2020 annual meeting.
The American College of Surgeons Clinical Congress 2020 (Oct. 3-7) is a virtual-only event. Here’s the listing of next week’s activities for media attendees.
After more than six months of living in a pandemic, large percentages of Americans continue to indulge in unhealthy lifestyle habits, including overeating and increased use of alcohol and marijuana — all while many are exercising less, according to a study of the cultural impact of COVID-19 conducted by the USC Center for the Digital Future (CDF).
Research from the Department of Psychological & Brain Sciences at Washington University in St. Louis shows prenatal cannabis exposure may impact child behavior later in life.
African American and Hispanic children are less likely to have surgery than white children. People who use cannabis need more pain medicine during and after surgery. Some good news—opioid abuse is down. These studies are among the significant and newsworthy research being presented at ANESTHESIOLOGY® 2020, the annual meeting of the American Society of Anesthesiologists (ASA) Oct. 2-5, which is all-virtual this year.
Although it has become increasingly accepted for medical and recreational use, cannabis is still considered among one of the most widely used illegal substances in the United States and in many European countries.
Legal marijuana is one of America’s fastest-growing industries, yet little scientific research exists on the unique workplace and health risks faced by cannabis workers. A special issue of the journal Annals of Work Exposures and Health explores worker safety in cannabis industry.
A longitudinal study of more than 230 teens and young adults in Washington state finds that teens may be more likely to use marijuana following legalization – with the proliferation of stores and increasing adult use of the drug -- than they otherwise would have been.
Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial co-led by University of California, Irvine researcher Kalpna Gupta and Dr. Donald Abrams of UC San Francisco. The findings appear in JAMA Network Open.
Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.
Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Toronto General Hospital. In the Medical Cannabis Real-World Evidence trial patients using the online portal created by Medical Cannabis by Shoppers, will know exactly what is in their product and its effectiveness.
Lyndsey Anderson traveled halfway around the world to do epilepsy research in Sydney, Australia. Recently, she was awarded ILAE's 2020 Epilepsia Prize for Basic Science Research.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.
In a sign that designer drugs are becoming more prevalent in Australia, synthetic cathinones – commonly known as ‘bath salts’ – have been detected in the nation’s wastewater in the largest study of its kind in the country.
Israeli researchers have developed an innovative drug delivery system that releases medical cannabis slowly to provide tailored treatment with a long-lasting effect. It could be tailored to specific treatment targets, such as seizures.
Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.
What happened between those two dates is the focus of a comprehensive new report.
Middle-aged and older adults who identify as lesbian, gay, or bisexual have higher rates of using certain substances in the past year than those who identify as heterosexual, according to a new study led by researchers at NYU Grossman School of Medicine and the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health.
Users of high-potency cannabis are four times more likely to report associated problems, and twice as likely to report anxiety disorder, than users of lower-potency strains, according to new research from the University of Bristol.
The use of medical cannabis has garnered a lot of recent attention, especially as parts of the United States and Canada have legalized its use. While it has been studied in cancer and nerve pain, not much is known about the usage rate and its efficacy in managing chronic musculoskeletal (MSK) pain. According to a new study released as part of the American Academy of Orthopaedic Surgeons’ (AAOS) Virtual Education Experience, up to 20% of patients presenting to an orthopaedic surgeon with chronic MSK pain are using cannabis to manage their pain, with many reporting success. Additionally, two-thirds of non-users are interested in using it for the management of MSK pain, prompting a need to further study its effects.
More farmers are growing non-intoxicating strains of cannabis, or hemp, for CBD production. This new market has led to commercial genetic tests for early determination of hemp plant sex. A new study has found that these tests may not all produce accurate results.
Findings from a new study examining human and canine brain cancer cells suggest that cannabidiol could be a useful therapy for a difficult-to-treat brain cancer. Cannabidiol, or CBD, is a non-psychoactive chemical compound derived from marijuana.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday, throughout the duration of the outbreak.
Medical marijuana users who say they have high levels of pain are more likely than those with low pain to say they use cannabis three or more times a day, a new study finds.
Female eggs exposed to THC, the psychoactive ingredient in marijuana, have an impaired ability to produce viable embryos, and are significantly less likely to result in a viable pregnancy, according to an animal study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting. The abstract will be published in the Journal of the Endocrine Society.
Cannabis use can worsen some consequences of alcohol use among young adult drinkers over time, according to a new study which tracked the frequency of cannabis use and negative drinking outcomes among college students over three years. More than one in five young drinkers use cannabis, often (but not always) at the same time as drinking alcohol. This is a concern because the effects of cannabis might combine with those of alcohol to increase negative outcomes of drinking, such as impaired driving or developing an alcohol use disorder Although previous research has suggested a link between cannabis use and alcohol consequences, there have been few long-term evaluations of the impact of fluctuations in cannabis use on alcohol consequences over time. The latest study, published in the journal Alcoholism: Clinical and Experimental Research, was conducted by researchers in Toronto, Ontario, and Buffalo, New York.
A new study of more than 1,800 adult twins found that individuals who started using cannabis regularly before age 18 were far more likely to suffer insomnia and sleep fewer than six hours per night as adults.
Currently, no breatalyzer test exists for cannabis intoxication, although the substance is known to impair driving, among other activities. Scientists now report that they are one step closer to a convenient saliva test for measuring cannabis levels at roadside stops.